← Eichor
Condition: High Risk Human Papillomavirus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Risk Human Papillomavirus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

High Resolution Anuscopy Study
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06697964Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413HUC-MSC for Treatment of High-risk HPV Infection
Phase 1/Phase 2 · 1 location(s) · Shanghai East Hospital · NCT06610773A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Screening Women With Prior HPV for Anal Neoplasia
NA · 3 location(s) · Icahn School of Medicine at Mount Sinai · NCT05217940Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06327568Safety of Anal Curcumin
Phase 1 · 2 location(s) · Lisa Flowers · NCT06626230A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NA · 1 location(s) · Karolinska Institutet · NCT07275333Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NA · 1 location(s) · University Hospital, Toulouse · NCT04901351Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HS
Phase 2 · 5 location(s) · Frantz Viral Therapeutics, LLC · NCT06075264Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV
Phase N/A · 1 location(s) · Fondation Hôpital Saint-Joseph · NCT05566106Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Phase N/A · 8 location(s) · International Vaccine Institute · NCT06129253Effect of Honey For CIN II
Phase 1/Phase 2 · 2 location(s) · Zuyderland Medisch Centrum · NCT06219018Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT06291311
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.